Canopy Growth (CGC) Other Non-Current Assets (2017 - 2026)

Canopy Growth (CGC) reported Other Non-Current Assets of $12.2 million for Q1 2026, up 6.43% on a YoY basis from $11.4 million in Q1 2025, and down 95.77% sequentially from $287.4 million in Q4 2025.

Canopy Growth (CGC) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Canopy Growth (CGC) has 10 years of Other Non-Current Assets data on file, last reported at $12.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 6.43% year-over-year to $12.2 million; the trailing twelve-month figure through Mar 2026 stood at $12.2 million (up 6.43% YoY), and the FY2026 full-year result was $12.2 million, up 6.43% from the prior year.
  • Other Non-Current Assets slipped to $12.2 million in Q1 2026, from $287.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $359.0 million in Q4 2024 to a low of $4.8 million in Q4 2022.
  • A 5-year average of $49.7 million and a median of $12.2 million in 2025 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets plunged 60.51% in 2022 and jumped 1827.17% in 2024, its largest moves.
  • Tracing CGC's Other Non-Current Assets over 5 years: stood at $4.8 million in 2022, then soared by 291.34% to $18.6 million in 2023, then jumped by 1827.17% to $359.0 million in 2024, then declined by 19.95% to $287.4 million in 2025, then sank by 95.77% to $12.2 million in 2026.
  • Business Quant data shows CGC's Other Non-Current Assets at $12.2 million in Q1 2026, $287.4 million in Q4 2025, and $12.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Canopy Growth 197.77 Mn -68.15 Mn - 12.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.15 Mn
Dec 31, 2025 287.36 Mn
Sep 30, 2025 12.17 Mn
Jun 30, 2025 11.86 Mn
Mar 31, 2025 11.42 Mn
Dec 31, 2024 358.98 Mn
Sep 30, 2024 13.99 Mn
Jun 30, 2024 16.49 Mn
Mar 31, 2024 5.97 Mn
Dec 31, 2023 18.63 Mn
Sep 30, 2023 26.51 Mn
Jun 30, 2023 14.52 Mn
Mar 31, 2023 14.79 Mn
Dec 31, 2022 4.76 Mn
Sep 30, 2022 11.12 Mn
Jun 30, 2022 11.34 Mn
Mar 31, 2022 12.11 Mn
Dec 31, 2021 12.05 Mn
Sep 30, 2021 7.12 Mn
Jun 30, 2021 7.74 Mn